Ursprung des Netzwerks ersten Grades von Soo-Yeon Jang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Pelemed Co., Ltd.
 Pelemed Co., Ltd. Pharmaceuticals: GenericHealth Technology Pelemed Co., Ltd. is a South Korean company based in Seoul that specializes in the development of innovative anticancer drugs. Pelemed's technology platform, PeLeSeLect & AHEDD, overcomes mutation-mediated drug resistance and enables precision drug design for kinase-targeted therapies. The company's pipeline includes several drugs in various stages of development for the treatment of different types of cancer. Pelemed has received funding from the IP Voucher Funded by MSS and has a scientific advisory board that includes experts from the ASAN Medical Center Bio Core Facility. The company was founded in 2019, and its CEOs are Yong-Chul Kim and Soo-Yeon Jang.
2
| Holding Company | Pharmaceuticals: Generic | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Soo-Yeon Jang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| KOREA UNITED PHARM INC. | Pharmaceuticals: Major | Director/Board Member | |
| Seoul National University | College/University | Corporate Officer/Principal |
Statistik
International
| Südkorea | 3 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Gun-Wook Kang | 3 |
| Yong-Chul Kim | 1 |
- Börse
- Insiders
- Soo-Yeon Jang
- Unternehmensverbindungen
